Vav guanine nucleotide exchange factor 2 mRNA 3′ untranslated region (VAV2 mRNA 3′UTR)

The VAV2 mRNA 3′ untranslated region (3′UTR) is a regulatory sequence located at the 3′ end of the Vav guanine nucleotide exchange factor 2 (VAV2) transcript. VAV2 is a critical guanine nucleotide exchange factor (GEF) that activates Rho-family GTPases, particularly RAC1, thereby regulating cellular processes such as actin cytoskeleton reorganization, cell motility, and proliferation (UniProt, 1.1.5). The 3′UTR of VAV2 mRNA contains binding sites for several microRNAs (miRNAs), such as miR-331-3p, miR-148a, and miR-195, which act as post-transcriptional repressors by promoting mRNA decay or inhibiting translation (NIH, 1.4.1; Oncotarget, 1.5.2). In many cancers, including breast, lung, and head and neck squamous cell carcinomas, the loss of these regulatory miRNAs leads to VAV2 overexpression, which drives tumor progression, invasion, and metastasis (OncoKB, 1.2.2; NIH, 1.3.2). Beyond oncology, the VAV2 mRNA 3′UTR is involved in cardiovascular diseases and atherosclerosis, where VAV2 levels influence macrophage foam cell formation and vascular homeostasis (NIH, 1.2.1). As a result, the VAV2 mRNA 3′UTR is being explored as a therapeutic target for RNA-based strategies, including miRNA mimics and antisense oligonucleotides, to restore normal VAV2 expression levels in pathological conditions (Oncotarget, 1.5.1). These interventions aim to leverage the natural RNA interference machinery to downregulate VAV2 in tissues where its activity is pathologically elevated. Understanding the structural and sequence-specific interactions within the 3′UTR is essential for developing precise and effective RNA-targeted therapies.

Other names

VAV2 3′UTRVAV2 3-prime untranslated regionVav2 mRNA 3-prime untranslated region

RNA interference (RNAi), translational repression, and mRNA degradation mediated by microRNA binding or antisense mechanisms.